BMRN fund manager activity
BioMarin Pharmaceutical Inc · Nasdaq. Reported by 9 tracked fund managers in their 13F filings, Q1 2014 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Dodge & Cox Funds | Trimmed | 14,572,384 | $866,036,781 | 0.47% | Feb 13, 2026 |
| Ken Fisher - Fisher Asset Management | Added | 35,290 | $2,097,328 | 0.00% | Feb 9, 2026 |
| Joel Greenblatt - Gotham Asset Management | Added | 269,511 | $16,017,039 | 0.06% | Feb 17, 2026 |
| Viking Global Investors | Trimmed | 6,036,936 | $358,775,106 | 0.95% | Feb 17, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Dodge & Cox Funds | Trimmed | 14,686,801 | $795,437,142 | 0.43% | Nov 13, 2025 |
| Ken Fisher - Fisher Asset Management | Added | 31,726 | $1,718,319 | 0.00% | Nov 12, 2025 |
| Joel Greenblatt - Gotham Asset Management | Added | 265,332 | $14,370,381 | 0.06% | Nov 14, 2025 |
| Viking Global Investors | Trimmed | 8,322,179 | $450,729,215 | 1.17% | Nov 14, 2025 |
Newer quarters · Older quarters